October 29, 2026

Medical Oddities: The ghost that haunted a heart

From haunted hearts to toxic treats, medicine has a few Halloween tricks up its sleeve.

MDSpire News

October 28, 2026

NUT carcinoma may defy typical staining patterns

Two pulmonary cases highlight how limited squamous differentiation and variable keratin expression may complicate pathological diagnosis.

MDSpire News

October 26, 2026

Cryptococcal cellulitis may lead to amputation

A splinter injury progressed to finger necrosis in a patient with MDS, despite antibacterial treatment and no clinically apparent systemic dissemination.

MDSpire News

October 26, 2026

Vampire bats may link Chagas cycles

Molecular screening detected Trypanosoma cruzi in 42% of sampled bats in northern Belize, raising questions about their role in parasite transmission.

MDSpire News

October 23, 2026

FDA raises TMB threshold for pembrolizumab

Traditional approval narrows eligibility for previously treated solid tumors after efficacy was not confirmed at lower biomarker levels.

MDSpire News

October 22, 2026

Medical Oddities: When puberty arrives at 4 months old

A genetic mystery, hearts in space, midnight munchies, and tea with muscle power are in the lineup this week.

MDSpire News

October 22, 2026

STAT6 may aid diagnosis of giant pulmonary SFT

Immunohistochemical testing confirmed a rare tumor despite low-grade histology, extensive local involvement, and suspected liver metastasis.

MDSpire News

October 19, 2026

FDA approves dostarlimab for advanced rectal cancer

The accelerated approval adds an immunotherapy option for patients with MSI-H/dMMR stage II/III disease.

MDSpire News

October 16, 2026

21-day cold-stored platelets may maintain hemostasis

A randomized cardiac surgery trial found noninferior bleeding control with refrigerated platelets, although reexploration rates and blood product requirements were higher.

MDSpire News

October 15, 2026

AI may predict focal GBM recurrence

Optical analysis of resection-margin tissue identified tumor infiltration as the strongest contributor to predictions of where glioblastoma later recurred.

MDSpire News